Literature DB >> 14735293

Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.

Thomas J R Beveridge1, Annis O Mechan, Marie Sprakes, Qi Pei, Tyra S C Zetterstrom, A Richard Green, J Martin Elliott.   

Abstract

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) administration to rats produces an acute hyperthermic response and induces localised neuronal activation, which can be visualised via expression of immediate-early genes. The pharmacological and anatomical basis of these effects are unclear. At high doses, MDMA also causes selective neurotoxicity at serotonergic nerve terminals.
OBJECTIVE: We investigated the effect of 5-hydroxytryptamine (5-HT) depletion on the acute hyperthermic response to MDMA and the pattern of neuronal excitation indicated by Arc (activity-regulated cytoskeleton associated gene) in naive rats and following administration of MDMA at a neurotoxic dose.
METHODS: Expression of Arc mRNA was investigated by in situ hybridisation histochemistry using 35S-labelled oligonucleotide probe.
RESULTS: MDMA induced a significant hyperthermia together with increased Arc mRNA expression in cortical regions, caudate-putamen and CA1 hippocampus but not hypothalamus. At 21 days after a neurotoxic dose of MDMA, brain 5-HT and 5-HIAA levels were significantly reduced by 21-32%. In these animals, both the hyperthermic response and the pattern and extent of Arc mRNA expression induced by a subsequent dose of MDMA were unaltered. However, basal Arc expression was significantly increased in cortical regions and CA1 hippocampus.
CONCLUSION: We conclude that the acute hyperthermic response induced by MDMA is not attenuated by moderate depletion of 5-HT, further questioning mediation via a serotonergic mechanism. Arc mRNA induction by MDMA exhibits highly localised expression, which is not altered following 5-HT depletion. However, following a neurotoxic dose of MDMA, basal expression of Arc is increased, particularly in cortex and CA1, suggesting that mechanisms underlying synaptic plasticity might also be modified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735293     DOI: 10.1007/s00213-003-1753-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.

Authors:  Elena Castro; Rosa M Tordera; Zoe A Hughes; Qi Pei; Trevor Sharp
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

2.  A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.

Authors:  M Shankaran; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

3.  Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.

Authors:  B Gough; S F Ali; W Slikker; R R Holson
Journal:  Pharmacol Biochem Behav       Date:  1991-07       Impact factor: 3.533

4.  Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.

Authors:  W Slikker; R R Holson; S F Ali; M G Kolta; M G Paule; A C Scallet; D E McMillan; J R Bailey; J S Hong; F M Scalzo
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

5.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

6.  Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats.

Authors:  A Malpass; J M White; R J Irvine; A A Somogyi; F Bochner
Journal:  Pharmacol Biochem Behav       Date:  1999-09       Impact factor: 3.533

7.  The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain.

Authors:  C P Stephenson; G E Hunt; A N Topple; I S McGregor
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

8.  3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation.

Authors:  Y Shirayama; K Hashimoto; M Iyo; K Watanabe; T Higuchi; Y Minabe
Journal:  Eur J Pharmacol       Date:  2000-08-25       Impact factor: 4.432

9.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

Authors:  E O'Shea; R Granados; B Esteban; M I Colado; A R Green
Journal:  Neuropharmacology       Date:  1998-07       Impact factor: 5.250

View more
  6 in total

Review 1.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat.

Authors:  Csaba Adori; Péter Low; Rómeó D Andó; Lise Gutknecht; Dorottya Pap; Ferencné Truszka; József Takács; Gábor G Kovács; Klaus-Peter Lesch; György Bagdy
Journal:  Psychopharmacology (Berl)       Date:  2010-10-30       Impact factor: 4.530

3.  The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.

Authors:  Kathryn S Saadat; Esther O'shea; M Isabel Colado; J Martin Elliott; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2005-01-14       Impact factor: 4.530

4.  Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects.

Authors:  Sami Ben Hamida; Erin Plute; Brigitte Cosquer; Christian Kelche; Byron C Jones; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2007-11-27       Impact factor: 4.415

5.  Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination.

Authors:  Sami Ben Hamida; Erin Plute; Sonia Bach; Christine Lazarus; Antoine Tracqui; Christian Kelche; Anne Pereira de Vasconcelos; Byron C Jones; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415

6.  Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.

Authors:  Alvaro Llorente-Berzal; Emma Puighermanal; Aurelijus Burokas; Andrés Ozaita; Rafael Maldonado; Eva M Marco; Maria-Paz Viveros
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.